Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;15(2):206-216.
doi: 10.2174/1570159x14666160210142339.

The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain

J E Pope  1 , T R Deer, K Amirdelfan, W P McRoberts, N Azeem
Affiliations
Review

The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain

J E Pope et al. Curr Neuropharmacol. 2017.

Abstract

Background: Intrathecal drug delivery has undergone a revitalization following a better understanding of this delivery route and its pharmacokinetics. Driven by patient safety and outcomes, clinicians are motivated to rethink the traditional spinal infusion pump patient selection criteria and indications. We review the current understanding of the pharmacology of commonly employed intrathecal agents and the clinical relevance.

Methods: Search strategies for data acquisition included Medline database, PubMed, Google scholar, along with international and national professional meeting content, with key words including pharmacology of opioids, intrathecal therapy, ziconotide, pharmacokinetics, and intrathecal drug delivery. The search results were limited to the English language.

Results: Over 300 papers were identified. The literature was condensed and digested to evaluate the most commonly used medications in practice, sto serve as a foundation for review. We review on-label medications: ziconotide and morphine, and off label medications including fentanyl, sufentail, and hydromorphine.

Conclusion: Intrathecal therapy has level-one evidence for use for malignant pain and nonmalignant pain, with continued cost savings and improved safety. To most effectively serve our patients, a clear appreciation for the pharmacology of these commonly employed medication is paramount.

PubMed Disclaimer

References

    1. Bernards C.M. Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs. Anesthesiology. 2006;105(1):169–178. [http://dx.doi.org/10.1097/ 00000542-200607000-00027]. [PMID: 16810009]. - PubMed
    1. Deer T.R., Prager J., Levy R., Burton A., Buchser E., Caraway D., Cousins M., De Andrés J., Diwan S., Erdek M., Grigsby E., Huntoon M., Jacobs M., Kim P., Kumar K., Leong M., Liem L., McDowell G., Panchal S.J., Rauck R., Saulino M., Staats P., Stanton-Hicks M., Stearns L., Sitzman B.T., Wallace M., Willis K.D., Witt W., Yaksh T., Mekhail N. Polyanalgesic Consensus Conference2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012;15(5):420–435. [http://dx.doi.org/ 10.1111/j.1525-1403.2012.00450.x]. [PMID: 22494357]. - PubMed
    1. Kumar K., Hunter G., Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery. 2006;58(3):481–496. [http://dx.doi.org/10.1227/01.NEU.0000192162. 99567.96]. [PMID: 16528188]. - PubMed
    1. (Centers for Disease Control). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999-2008. MMWR. 2011;60:1–6. - PubMed
    1. Hayek S.M., Deer T.R., Pope J.E., Panchal S.J., Patel V.B. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011;14(3):219–248. [PMID: 21587327]. - PubMed

MeSH terms

LinkOut - more resources